A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears

Cancer Cytopathology

Volumn 122, Issue 4, 2014, Pages 274-281

  Fassina, Ambrogio ^a   Cappellesso, Rocco ^a   Simonato, Francesca ^a   Siri, Maayan ^a   Ventura, Laura ^a   Tosato, Francesca ^a   Busund, Lill Tove ^b   Pelizzo, Maria Rosa ^a   Fassan, Matteo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Fine needle cytology; Mantel zone lymphoma; MicroRNAs; Primary thyroid lymphoma; Thyroid cancer

Indexed keywords

MICRORNA; MICRORNA 146B; MICRORNA 221; MICRORNA 222; MICRORNA 26A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GOITER; HUMAN; HUMAN CELL; LYMPHOMA; MALE; PRIMARY THYROID LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMEAR; THYROID CARCINOMA; UPREGULATION; VERY ELDERLY; COHORT ANALYSIS; COMPARATIVE STUDY; FINE NEEDLE ASPIRATION BIOPSY; FINE-NEEDLE CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MANTEL ZONE LYMPHOMA; METHODOLOGY; MIDDLE AGED; NODULAR GOITER; PATHOLOGY; PATHOPHYSIOLOGY; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; THYROID CANCER; THYROID TUMOR;

FINE-NEEDLE CYTOLOGY; MANTEL ZONE LYMPHOMA; MICRORNAS; PRIMARY THYROID LYMPHOMA; THYROID CANCER;

AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; MICRORNAS; MIDDLE AGED; RARE DISEASES; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; ROC CURVE; THYROID NEOPLASMS; UP-REGULATION;

EID: 84901803848     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21383     Document Type: Article

References (31)

1. DeLellis R, Lloyd R, Heitz P, Eng C, eds. Pathology and Genetics of Endocrine Tumors. World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2004.
2. Tallini G, Gallo C. Fine-needle aspiration and intraoperative consultation in thyroid pathology: when and how? Int J Surg Pathol. 2011;19:141-144
3. Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol. 2006;94:725-736 (Pubitemid 44902073)
4. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26:316-323 (Pubitemid 29272899)
5. Burke JS, Butler JJ, Fuller LM. Malignant lymphomas of the thyroid: a clinical pathologic study of 35 patients including ultrastructural observations. Cancer. 1977;39:1587-1602 (Pubitemid 8108317)
6. Souhami L, Simpson WJ, Carruthers JS. Malignant lymphoma of the thyroid gland. Int J Radiat Oncol Biol Phys. 1980;6:1143-1147 (Pubitemid 10016467)
7. Thieblemont C, Mayer A, Dumontet C, et al. Primary thyroid lymphoma is a heterogeneous disease. J Clin Endocrinol Metab. 2002;87:105-111 (Pubitemid 34084678)
8. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology. 1996; 28:25-32 (Pubitemid 26040138)
9. de la Chapelle A, Jazdzewski K. MicroRNAs in thyroid cancer. J Clin Endocrinol Metab. 2011;96:3326-3336
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233
11. Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013;329:125-136
12. Simonato F, Ventura L, Sartori N, et al. Detection of microRNAs in archival cytology urine smears [serial online]. PLoS One. 2013;8: e57490
13. Fassina A, Cappellesso R, Fassan M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using micro- RNA expression profiling. Chest. 2011;140:1305-1311
14. Esposito F, Tornincasa M, Pallante P, et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab. 2012;97:E710-E718
15. Zhang Z, Liu ZB, Ren WM, Ye XG, Zhang YY. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells. Int J Mol Med. 2012;30:856-862
16. Pallante P, Visone R, Croce CM, Fusco A. Deregulation of micro- RNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer. 2010;17:F91-F104
17. Fassina A, Corradin M, Zardo D, Cappellesso R, Corbetti F, Fassan M. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306-312
18. Fassina A, Marino F, Siri M, et al. The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest. 2012;92:1574-1582
19. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392 (Pubitemid 24273002)
20. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am. 2012;96:329-349
21. Hambleton C, Kandil E. Appropriate and accurate diagnosis of thyroid nodules: a review of thyroid fine-needle aspiration. Int J Clin Exp Med. 2013;6:413-422
22. Hoang JK, Lee WK, Lee M, Johnson D, Farrell S. US features of thyroid malignancy: pearls and pitfalls. Radiographics 27:847-860, 2007; discussion 861-865
23. Scopa CD. Histopathology of thyroid tumors. an overview. Hormones (Athens). 2004;3:100-110
24. Sangalli G, Serio G, Zampatti C, Lomuscio G, Colombo L. Fine needle aspiration cytology of primary lymphoma of the thyroid: a report of 17 cases. Cytopathology. 2001;12:257-263 (Pubitemid 32695182)
25. Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013;98:3131-3138
26. Fassina A, Cappellesso R, Simonato F, Lanza C, Marzari A, Fassan M. Fine needle aspiration of non-small cell lung cancer: current state and future perspective. Cytopathology. 2012;23:213-219
27. Chou CK, Chen RF, Chou FF, et al. miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid. 2010;20:489-494
28. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ, Scognamiglio T. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol. 2008;21:1139-1146
29. Chou CK, Yang KD, Chou FF, et al. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98:E196-E205
30. Visone R, Pallante P, Vecchione A, et al. Specific microRNAs are down-regulated in human thyroid anaplastic carcinomas. Oncogene. 2007;26:7590-7595 (Pubitemid 350207711)
31. Sander S, Bullinger L, Klapproth K, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008;112:4202-4212